Tissium raises €60M to take its sutureless nerve glue to the US
Tissium has raised €60M to carry the world’s only FDA-cleared sutureless nerve repair system into US operating rooms. The Paris medtech wants to swap the surgeon’s needle for a dab of light-cured glue.
For a severed nerve, the standard repair has barely changed in decades. A surgeon stitches the two frayed ends together under a microscope. The hope is that the needle will not damage the very tissue it is meant to mend. The results vary. One recent meta-analysis found that only 54% of patients regain meaningful function after the operation.
Paris-based Tissium thinks it has a better way. The medtech has just closed a €60M financing package. The cash will push its sutureless system into US operating rooms. Its first product is already on sale there.
The deal
The money comes in two halves. The first is a €30M Series D2 round, completed at the end of 2025....
Copyright of this story solely belongs to thenextweb.com. To see the full text click HERE
